Keyword Suggestion
Domain Informations
Network
- inetnum : 23.192.0.0 - 23.223.255.255
- name : AKAMAI
- handle : NET-23-192-0-0-1
- status : Direct Allocation
- created : 1999-01-21
- changed : 2023-10-24
Owner
- organization : Akamai Technologies, Inc.
- handle : AKAMAI
- address : Array,Cambridge,MA,02142,US
Technical support
- handle : SJS98-ARIN
- name : Schecter, Steven Jay
- phone : +1-617-274-7134
- email : [email protected]
Abuse
- handle : NUS-ARIN
- name : NOC United States
- phone : +1-617-444-2535
- email : [email protected]
| Domain Provider | Number Of Domains |
|---|---|
| godaddy.com | 286730 |
| namecheap.com | 101387 |
| networksolutions.com | 69118 |
| tucows.com | 52617 |
| publicdomainregistry.com | 39120 |
| whois.godaddy.com | 32793 |
| enomdomains.com | 23825 |
| namesilo.com | 21429 |
| domains.google.com | 21384 |
| cloudflare.com | 20573 |
| gmo.jp | 18110 |
| name.com | 17601 |
| fastdomain.com | 14708 |
| register.com | 13495 |
| net.cn | 12481 |
| ionos.com | 12416 |
| ovh.com | 12416 |
| gandi.net | 12305 |
| registrar.amazon.com | 12111 |
Host Informations
- IP address: 23.212.185.194
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
Site Inspections
Port Scanner (IP: 23.212.185.194)
Spam Check (IP: 23.212.185.194)
Recent Searched Sites
› Onlinetraining.pwna.org (7 seconds ago) / US
› Tienda.ipool.mx (0 seconds ago) / US
› Kittenflood8.bravejournal.net (6 seconds ago) / US
› Zg.sbl1.pro (7 seconds ago) / US
› Meetcody.ai (12 seconds ago) / US
› Animaltrapper.com (7 seconds ago) / US
› Sinnerz.net (35 seconds ago) / US
› Diyfaq.org.uk (18 seconds ago) / GB
› Pelisflix-flg1.s3.amazonaws.com (6 seconds ago) / US
› Amarillocityjail.org (14 seconds ago) / US
› Cms.bamdc.edu.pk (1 seconds ago) / US
› Criswellauto.avanan.net (17 seconds ago) / US
› Turoism.com (4 seconds ago) / US
› Gap.com.tr (2 seconds ago) / DE
› Oldskoolfalcon.com (2 seconds ago) / US
› Uqiulive66.com (22 seconds ago) / HK
› Assai.novatek.ru (4 seconds ago) / RU
› Investors.soleno.life (0 seconds ago) / US
› Snowleopardhaven.com (0 seconds ago) / US
› Gc.adventistas.org (1 seconds ago) / GB
Websites Listing
We found Websites Listing below when search with investors.soleno.life on Search Engine
IR Contacts – Soleno Therapeutics Inc.
[email protected]. Investors. [email protected]. Media. [email protected]. Print Page RSS Feeds Email Alerts IR Contacts Developing novel therapeutics for the treatment of rare diseases. Pages. Company . Management ...
Investors.soleno.lifeSoleno Therapeutics Inc.
Soleno Therapeutics Inc.
Investors.soleno.lifeContact us - Soleno
Email: [email protected] For more information on Soleno Therapeutics and our products, please fill out the information to the right and click Submit. Soleno does not share any information with third parties. Developing novel therapeutics for the treatment of rare diseases. Pages Company For Patients Investors Contact us News and Events
Soleno.lifeHome Page - Soleno
2022-03-31 · Investors; Contact us; News and Events. Soleno Therapeutics Announces Presentation of Long-Term Hyperphagia and Behavioral Data in Patients Receiving DCCR for Treatment of Prader-Willi Syndrome. Soleno Therapeutics Announces Closing of Approximately $15 Million Underwritten Public Offering . Contact Us. 203 Redwood Shores Parkway; Suite …
Soleno.lifeAdvisors - Soleno
Soleno Therapeutics, Inc. is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. We are committed to developing safe and effective therapeutic products that improve the lives of patients living with complex, life-threatening rare diseases with unmet medical needs.
Soleno.lifeCompany - Soleno
Soleno Therapeutics, Inc. is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. We are committed to developing safe and effective therapeutic products that improve the lives of patients living with complex, life-threatening rare diseases with unmet medical needs. Management.
Soleno.lifeContact us : head Office, customer service and Plants - Soleno
Head Office. Soleno inc. 1160, route 133 Saint-Jean-sur-Richelieu, QC J2X 4B6 Canada T 450.347.7855 F 450.359.4150 [email protected]. Soleno Textile inc. 1261, rue Berlier
Soleno.comClinical Trials - Soleno
Investors; Contact us; News and Events. Soleno Therapeutics Announces Presentation of Long-Term Hyperphagia and Behavioral Data in Patients Receiving DCCR for Treatment of Prader-Willi Syndrome. Soleno Therapeutics Announces Closing of Approximately $15 Million Underwritten Public Offering . Contact Us. 203 Redwood Shores Parkway; Suite 500; Redwood City, CA …
Soleno.lifeCompleted Studies - Soleno
Investors; Contact us; News and Events. Soleno Therapeutics Announces Presentation of Long-Term Hyperphagia and Behavioral Data in Patients Receiving DCCR for Treatment of Prader-Willi Syndrome. Soleno Therapeutics Announces Closing of Approximately $15 Million Underwritten Public Offering . Contact Us. 203 Redwood Shores Parkway; Suite 500; Redwood City, CA …
Soleno.lifeSoleno Therapeutics - Crunchbase Company Profile
Founded Date Aug 25, 1999. Operating Status Active. Last Funding Type Post-IPO Equity. Legal Name Soleno Therapeutics, Inc. Stock Symbol NASDAQ:SLNO. Company Type For Profit. Contact Email [email protected]. Phone Number (650) 213-8444. Soleno Therapeutics is a clinical-stage biopharmaceutical company.
Crunchbase.comContact The Board – Soleno Therapeutics Inc.
You can contact Soleno Therapeutics's Board of Directors to provide comments, to report concerns, or to ask a question, at the following address: Chairman of the Board Soleno Therapeutics, Inc. 203 Redwood Shores Parkway Suite 500 Redwood City, CA 94065 United States. You may submit your concern anonymously or confidentially by postal mail. You ...
Investors.soleno.lifeIn The News – Soleno Therapeutics Inc.
Investors Investor Overview ... Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2022 Financial Results. Soleno Therapeutics Announces Presentation of Long-Term Hyperphagia and Behavioral Data in Patients Receiving DCCR for Treatment of Prader-Willi Syndrome . Contact Us. 203 Redwood Shores Pkwy; Ste 500; Redwood City, CA 94065 Tel: …
Investors.soleno.lifeCareers - Soleno
Investors; Contact us; News and Events. Soleno Therapeutics Announces Presentation of Long-Term Hyperphagia and Behavioral Data in Patients Receiving DCCR for Treatment of Prader-Willi Syndrome. Soleno Therapeutics Announces Closing of Approximately $15 Million Underwritten Public Offering . Contact Us. 203 Redwood Shores Parkway; Suite 500; Redwood City, CA …
Soleno.lifeOur involvement : social and environmental commitment - Soleno
Solenours. Parrainage Civique du Haut-Richelieu. Social commitment. Soleno is actively involved with Parrainage civique du Haut-Richelieu, a non-profit organization: Our president was the keynote speaker for its benefit lunch. Over 250 Solenours were given away (Soleno’s plush bear) L’Étoile, pédiatrie sociale.
Soleno.comSoleno Therapeutics Company Profile: Stock Performance
Soleno Therapeutics General Information Description. Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its product candidates comprise Diazoxide Choline Controlled-Release tablets, which is an oral tablet for the treatment of Prader-Willi Syndrome.
Pitchbook.comSLNO: Soleno Therapeutics - Full Company Report - Zacks.com
2022-04-25 · At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led ...
Zacks.comSoleno Therapeutics Provides Corporate Update and Reports First …
2022-05-10 · Story continues. First Quarter Ended March 31, 2022 Financial Results. Research and development expenses were $4.0 million for the quarter ended March 31, 2022, compared to $7.2 million in the ...
Finance.yahoo.comSoleno Therapeutics, Inc. (SLNO) Earnings Transcripts
2022-04-26 · All earnings call transcripts on Soleno Therapeutics, Inc. (SLNO) stock. Read or listen to the conference call. Download the investor presentation - earnings call slides.
Seekingalpha.comSoleno Therapeutics, Inc. (SLNO) Company Profile & Facts - Yahoo
See the company profile for Soleno Therapeutics, Inc. (SLNO) including business summary, industry/sector information, number of employees, business …
Finance.yahoo.comSoleno Therapeutics Institutional Ownership - MarketBeat
2022-05-06 · Of the 48 institutional investors that purchased Soleno Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Nantahala Capital Management LLC ($5.10M), Granite Point Capital Management L.P. ($3.05M), Vivo Capital LLC ($2.02M), BlackRock Inc. ($1.56M), AWM Investment Company …
Marketbeat.com
Domains Expiration Date Updated
| Site | Provider | Expiration Date |
|---|---|---|
| waspacegrant.org | networksolutions.com | -3 Years, -234 Days |
| stdworkflow.com | godaddy.com | -3 Years, -149 Days |
| erotskioglasi.com | namecheap.com | -3 Years, -251 Days |
| dcbsdcon.org | namecheap.com | -2 Years, -352 Days |
| onculanalitikfelsefe.com | godaddy.com | -3 Years, -247 Days |
| mendeez.com | publicdomainregistry.com | -3 Years, -198 Days |
| nickelmania.com | wildwestdomains.com | -3 Years, -331 Days |
| dorinatr.com | 1api.net | -2 Years, -328 Days |
| rogards.com | networksolutions.com | 1 Year, 96 Days |
| staycleansolutions.com | godaddy.com | -2 Years, -44 Days |